CNMD

CONMED Corporation
NYSEHEALTHCAREMEDICAL DEVICES

Key Statistics

Market Cap
$1.33B
P/E Ratio
24.58
EPS
$1.80
Beta
0.93
52W High
$56.43
52W Low
$31.44
50-Day MA
$36.70
200-Day MA
$39.89
Dividend Yield
0.92%
Profit Margin
4.00%
Forward P/E
27.17
PEG Ratio
1.84

About CONMED Corporation

CONMED Corporation, a medical technology company, develops, manufactures and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company is headquartered in Largo, Florida.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$1.37B
Gross Profit (TTM)$742.87M
EBITDA$212.56M
Operating Margin10.60%
Return on Equity5.50%
Return on Assets3.76%
Revenue/Share (TTM)$44.30
Book Value$33.76
Price-to-Book1.29
Price-to-Sales (TTM)0.97
EV/Revenue1.558
EV/EBITDA11.45
Quarterly Earnings Growth (YoY)136.80%
Quarterly Revenue Growth (YoY)-1.30%
Shares Outstanding$30.11M
Float$29.81M
% Insiders0.43%
% Institutions116.81%

Historical Volatility

HV 10-Day
47.32%
HV 20-Day
63.97%
HV 30-Day
63.10%
HV 60-Day
54.89%
HV Rank
96.0%

Volatility is currently contracting

Analyst Ratings

Consensus ($39.00 target)
5
Hold
1
Strong Sell

Latest News

CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal® Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its AirSeal® Robotic Solution is now indicated for use with Intuitive's 8 mm hex cannulas used as part of the Intuitive da Vinci 5 platform (“dV5”). Alongside its existing indication for Intuitive 8 mm round cannulas, the AirSeal Robotic Solution now has an expanded indication for use across Intuitive's portfolio of da Vinci X, da Vinci Xi, and da Vinci 5 robotic systems. Building on the existing indication for I.

Business Wire7/22/2026Neutral
CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced its participation in the Society of Robotic Surgery (SRS) 2026 Annual Meeting, which is being held July 23-26, 2026 in Fort Lauderdale, FL. During the meeting, Professor Nikhil Vasdev, FRCS (Urol), MCh (Urol), DSc will present data from a prospective randomized controlled clinical trial conducted by Vasdev et al., which investigated differences in the levels of intraoperative and post-operative pain between two abdomi.

Business Wire7/20/2026Neutral
CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2026 after the market close on Wednesday, July 29, 2026. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed fro.

Business Wire7/2/2026Neutral
CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced the appointment of Celine Martin and Jeff Mirviss to its Board of Directors (“Board”), effective July 1, 2026. Ms. Martin will serve as a member of the Audit Committee and the Strategy Committee, and Mr. Mirviss will serve as a member of the Compensation Committee and the Corporate Governance and Nominating Committee. In connection with these appointments, CONMED is increasing the size of its Board to include a total.

Business Wire5/20/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CNMD and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 7/29/2026